In vivo studies with antisense oligonucleotides

Trends in Pharmacological Sciences

Volumn 18, Issue 1, 1997, Pages 12-18

  Akhtar, Saghir ^a   Agrawal, Sudhir ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b HYBRIDON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; PHOSPHOROTHIOIC ACID DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; CANCER; CLINICAL TRIAL; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

EID: 0031027349     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(96)01002-4     Document Type: Article

References (61)

1. 1 Agrawal, S., ed. (1996) Antisense Therapeutics, Humana Press
2. 2 Sharma, H. W. and Narayanan, R. (1995) Bioessays 17, 1055-1063
3. 3 Zamecnik, P. C., Goodchild, J., Taguchi, Y, and Sarin, P. S. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 4143-4146
4. 4 Matsukura, M. et al. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 7706-7710
5. 5 Agrawal, S. et al. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 7079-7083
6. 6 Wickstrom, E. (1986) J. Biochem. Biophys. Methods 13, 97-102
7. 7 Akhtar, S., Kole, R. and Juliano, R. L. (1991) Life Sci. 49, 1793-1801
8. 8 Agrawal, S., Temsamani, J., Galbraith, W. and Tang, J-Y. (1995) Clinical Pharmacokinetics, 28, 7-16
9. 9 Crook, S. T. (1992) Annu. Rev. Pharmacol. Toxicol. 32, 329-376
10. 10 Burch, R. M. and Mahan, L. C. (1991) J. Clin. Invest. 88, 1190-1196
11. 11 Simons, M., Edelman, R. R., Dekeyser, J. L., Langer, R. and Rosenberg, R. D. (1992) Nature 359, 67-70
12. 12 Ratajczak, M. Z. et al. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 11823-11827
13. 13 Kitajima, I. et al. (1992) Science 258, 1792-1795
14. 14 Higgins, K. A. et al. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9901-9905
15. 15 Pollio, G., Xue, P., Zanisi, M., Nicolin, A. and Maggi, A. (1993) Mol. Brain Res. 19, 135-139
16. 16 Offensperger W. B. et al. (1993). EMBO J. 12, 1257-1262
17. 17 Dean, N. M. and McKay, R., (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11762-11766
18. 18 Nesterova, M. and Cho-Chung, Y. S. (1995) Nat. Med. 1, 528-533
19. 19 Landgraf, R. et al. (1995). J. Neurosci. 15, 4250-4258
20. 20 Tomita, N. et al. (1995) Hypertension 26, 1331-1336
21. 21 Huang, Y., Synder, R., Kligshteyn, M., and Wickstrom, E., (1996) Mol. Med. 1, 647-658
22. 22 Leonetti, C. et al. (1996) J. Natl. Cancer. Inst. 88, 419-429
23. 23 Monia, B. P. et al. (1996) Nat. Med. 2 (6), 668-675
24. 24 Agrawal, S., Temsamani, J. and Tang, J-Y. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7595-7599
25. 25 Temsamani, J., Tang, J-Y. and Agrawal, S. (1992) Ann. New York Acad. Sci. 660, 318-320
26. 26 Cossum, P. A. et al. (1993) J. Pharmacol. Exp. Ther. 267, 1181
27. 27 Cossum, P. A. et al. (1994) J. Pharmacol. Exp. Ther. 267, 89-94
28. 28 Sands, H. et al. (1994) Mol. Pharmacol. 45, 932-943
29. 29 Lee, W. A. et al. (1995) Pharm. Res. 12, 1943-1947
30. 30 Zhang, R. et al. (1995) Clin. Pharmacol. Ther. 58, 44-53
31. 31 Zhang, R. et al. (1995) Clin. Chem. 41, 836-843
32. 32 Agrawal, S. et al. (1995) Biochem. Pharmacol. 50, 571-576
33. 33 Crook, S. T. et al. (1995) Clin. Pharmacol. Ther. 56, 641-646
34. 34 Sands, H. et al. (1995) Mol. Pharmacol. 47, 636-646
35. 35 Zhang, R. et al. (1995) Biochem. Pharmacol. 49, 929-939
36. 36 Wu, D., Boado, R. and Partridge, W. M. (1996) J. Pharmcol. Exp. Ther. 276, 206-211
37. 37 Whitesell, L. et al. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4665-4669
38. 38 Walker, I., Irwin, W. J. and Akhtar, S. (1995) Pharm. Res. 12, 1548-1553
39. 39 Lewis, K. J., Irwin, W. J. and Akhtar, S. (1995) J. Control. Release 37 (1-2), 173-183
40. 40 Hudson, A. J., Lewis, K. J., Rao, V. M. and Akhtar, S. (1996) Int. J. Pharm. 136, 23-29
41. 41 Coulson, J. M., Poyner, D. R., Chantry, A., Irwin, W. J. and Akhtar, S. (1996) Mol. Pharmacol. 50 (2), 314-325
42. 42 Krieg, A. M. and Stein, C. A. (1995) Antisense Res. Dev. 5, 241
43. 43 Iversen, P. L., Copple, B. L., Tewary, H. K., Bayever, E. and Bishop, M. R. (1996) in Antisense Therapeutics (Agrawal, S., ed.), pp. 201-212, Humana Press
44. 44 Zhang, R. et al. (1995) Biochem. Pharmacol. 50, 545-556
45. 45 Akhtar, S., ed. (1995) Delivery Strategies for Antisense Oligonucleotide Therapeutics, CRC Press
46. 46 Sarmiento, U., Perez, J. R., Becker, J. M. and Narayanan, R. (1994) Antisense Res. Dev. 4, 99-107
47. 47 McIntyre, K. W. et al. (1993) Antisense Res. Dev. 3, 309-322
48. 48 Branda, R. F., Moore, A. L., Mathews, L., McCormack, J. J. and Zon, G. (1993) Biochem. Pharmacol. 45, 2037-2043
49. 49 Yamamoto, S. et al. (1992) J. Immunol. 148, 4072-4076
50. 50 Yamamoto, T., Yamamoto, S., Kataoka, T. and Tokunaga, T. (1994) Antisense Res. Dev. 4, 119-122
51. 51 Kuramoto, E. et al. (1992) Cancer Res. 83, 1128-1131
52. 52 Krieg, A. M. et al. (1995) Nature 374, 546-549
53. 53 Zhao, G., Temsamani, J., Iadrola, P. L., Jiang, Z. and Agrawal, S. (1996) Biochem. Pharmacol. 51, 173-182
54. 54 Galbraith, W. M., Hobson, W. C., Giclas, P. C., Schechter, P. J. and Agrawal, S. (1994) Antisense Res. Dev. 4, 201-207
55. 55 Cornish, K. G., Iverson, P., Smith, L., Arneson, M. and Bayever, E. (1993) Pharmacol. Commun. 3, 239-247
56. 56 Agrawal, S., Rustagi, P. K. and Shaw, D. (1995) Toxicol. Lett. 82/83, 431-434
57. 57 Crooke, S. T. et al. (1996) J. Pharmcol. Exp. Ther. 277, 923-937
58. 58 Hutcherson, S. L. et al. (1995) Proceedings of the 35th Intnl. Conf. on Antimicrobial Agents and Chemotherapy, p. 204
59. 59 Padmapriya, A. A. A., Tang, J-Y. and Agrawal, S. (1994) Antisense Res. Dev. 4, 185-199
60. 60 Genet. Eng. News (1996) 16 (13), 1
61. 61 Agrawal, S. (1996) Trends Biotechnol. 14,